457 Targeting FASN sensitizes irradiated glioblastoma to immune checkpoint blockade

457 Targeting FASN sensitizes irradiated glioblastoma to immune checkpoint blockade

Bibliographic Details
Main Authors:	Claire Vanpouille-Box, Mara De Martino, Camille Daviaud
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Activin A backs-up TGF-ß to promote regulatory T cells
by: Mara De Martino, et al.
Published: (2021-01-01)

457 Semaphorin7a expression in breast cancer promotes susceptibility to immune checkpoint blockade
by: Alan Elder, et al.
Published: (2022-04-01)

Type I interferon induces cancer stem cells-mediated chemotherapy resistance
by: Mara De Martino, et al.
Published: (2022-12-01)

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
by: Víctor A. Arrieta, et al.
Published: (2023-01-01)

Activation of the complement system sensitizes immune checkpoint blockade
by: Fei Shao, et al.
Published: (2023-03-01)

897-F Wnt inhibition improves efficacy of immune checkpoint blockade in glioblastoma
by: Dai Fukumura, et al.
Published: (2023-11-01)

Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade
by: Hao Nie, et al.
Published: (2024-04-01)

Immunological barriers to immunotherapy in primary and metastatic breast cancer
by: Mara De Martino, et al.
Published: (2021-08-01)

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
by: Mathilde Bausart, et al.
Published: (2022-05-01)

Immune-Checkpoint Blockade Therapy in Lymphoma
by: Ayumi Kuzume, et al.
Published: (2020-07-01)

MCT4 blockade increases the efficacy of immune checkpoint blockade
by: Christian Schmidl, et al.
Published: (2023-10-01)

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
by: Crismita Dmello, et al.
Published: (2023-03-01)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
by: Dia Roy, et al.
Published: (2023-10-01)

The implications of FASN in immune cell biology and related diseases
by: Yucai Xiao, et al.
Published: (2024-01-01)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
by: Jan Christoph Banck, et al.
Published: (2021-03-01)

Acquired Resistance to Immune Checkpoint Blockade Therapies
by: Xianda Zhao, et al.
Published: (2020-05-01)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Brian J. Ahn, et al.
Published: (2013-11-01)

Targeting Metabolism to Control Immune Responses in Cancer and Improve Checkpoint Blockade Immunotherapy
by: Angèle Luby, et al.
Published: (2021-11-01)

Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma
by: William H. Tomaszewski, et al.
Published: (2022-10-01)

Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune “cold” tumors
by: Guixiu Xiao, et al.
Published: (2023-10-01)

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
by: Pfirschke, Christina, et al.
Published: (2018)

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
by: Zihao Yan, et al.
Published: (2021-12-01)

291 High Potency STING Agonists Induce Adaptive Immunity-Dependent Curative Responses in an Immune Checkpoint Blockade-Refractory Glioblastoma Model
by: Spencer Lea, et al.
Published: (2023-04-01)

NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients
by: Jean-Stéphane Giraud, et al.
Published: (2024-02-01)

Cold atmospheric plasma sensitizes head and neck cancer to chemotherapy and immune checkpoint blockade therapy
by: Yanhong Wang, et al.
Published: (2024-02-01)

ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade
by: Xiaolan Liu, et al.
Published: (2023-07-01)

Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade
by: Zhaohua Zhu, et al.
Published: (2022-12-01)

Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy
by: Jing Zhan, et al.
Published: (2023-03-01)

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
by: Xiong, Zhewen, et al.
Published: (2023)

Molecular patterns of resistance to immune checkpoint blockade in melanoma
by: Martin Lauss, et al.
Published: (2024-04-01)

Dynamic Collaborations for the Development of Immune Checkpoint Blockade Agents
by: Arisa Djurian, et al.
Published: (2021-05-01)

Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs
by: Maureen L. Drakes, et al.
Published: (2020-11-01)

Advanced Nanotechnology for Enhancing Immune Checkpoint Blockade Therapy
by: Chiara Cremolini, et al.
Published: (2021-03-01)

The Emerging Role of NK Cells in Immune Checkpoint Blockade
by: Alejandra Martinez-Perez, et al.
Published: (2022-12-01)

Metabolic predictors of response to immune checkpoint blockade therapy
by: Ofir Shorer, et al.
Published: (2023-11-01)

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
by: Melissa Sarver, et al.
Published: (2022-05-01)

Immune checkpoint alterations and their blockade in COVID-19 patients
by: Jiaxiong Tan, et al.
Published: (2022-10-01)

Combination approaches with immune checkpoint blockade in cancer therapy
by: Maarten Swart, et al.
Published: (2016-11-01)

Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer
by: Bhavana Palakurthi, et al.
Published: (2023-04-01)